Not applicableStudy completedNCT07169682
What this trial is testing
Effects of IL17/23 Inhibitors on Markers of Subclinical Atherosclerosis in Patients With Psoriasis
Who this might be right for
PsoriasisCardiovascular DiseaseAtherosclerosis
National and Kapodistrian University of Athens 66